ArticleDiagnostics (Basel, Switzerland)2023
CAD-ALZ: A Blockwise Fine-Tuning Strategy on Convolutional Model and Random Forest Classifier for Recognition of Multistage Alzheimer's Disease.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- X-ViTCNN: A Novel Network-Level Fusion of Transfer Learning and Customized Vision Transformer for Multi-Stage Alzheimer's Disease Prediction Using MRI Scans.Diagnostics (Basel, Switzerland) · 2026Article
- A new parallel-path ConvMixer neural network for predicting neurodegenerative diseases from gait analysis.Medical & biological engineering & computing · 2025Article
- Advanced interpretable diagnosis of Alzheimer's disease using SECNN-RF framework with explainable AI.Frontiers in artificial intelligence · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mental deterioration or Alzheimer's (ALZ) disease is progressive and causes both physical and mental dependency. There is a need for a computer-aided diagnosis (CAD) system that can help doctors make an immediate decision. (1) Background: Currently, CAD systems are developed based on hand-crafted features, machine learning (ML), and deep learning (DL) techniques. Those CAD systems frequently require domain-expert knowledge and massive datasets to extract deep features or model training, which causes problems with class imbalance and overfitting. Additionally, there are still manual approaches used by radiologists due to the lack of dataset availability and to train the model with cost-effective computation. Existing works rely on performance improvement by neglecting the problems of the limited dataset, high computational complexity, and unavailability of lightweight and efficient feature descriptors. (2) Methods: To address these issues, a new approach, CAD-ALZ, is developed by extracting deep features through a ConvMixer layer with a blockwise fine-tuning strategy on a very small original dataset. At first, we apply the data augmentation method to images to increase the size of datasets. In this study, a blockwise fine-tuning strategy is employed on the ConvMixer model to detect robust features. Afterwards, a random forest (RF) is used to classify ALZ disease stages. (3) Results: The proposed CAD-ALZ model obtained significant results by using six evaluation metrics such as the F1-score, Kappa, accuracy, precision, sensitivity, and specificity. The CAD-ALZ model performed with a sensitivity of 99.69% and an F1-score of 99.61%. (4) Conclusions: The suggested CAD-ALZ approach is a potential technique for clinical use and computational efficiency compared to state-of-the-art approaches. The CAD-ALZ model code is freely available on GitHub for the scientific community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.